Study estimates significant share aren’t aware of their own health status, including high cholesterol, diabetes and high ...

Discover how certain blood pressure medications are providing remarkable memory improvements in seniors, offering hope for ...

Halo Biosciences ("Halo"), a clinical-stage biotechnology company developing extracellular matrix-targeted therapies, today ...

Why People Smoke. Carl C. Seltzer has been engaged in research in physical anthropology at Harvard since 1937, and a survey which he made of the smoking habits of the class of 194 ...

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

Dr Ray O’Connor takes a look at the latest clinical articles on sleep – and how efforts to improve people's experience of it ...

Yutrepia is an inhaled dry powder formulation of treprostinil approved in the U.S. to improve exercise capacity in PAH and PH ...

Mineralys Therapeutics, Inc.'s lorundrostat shows promise for treating aldosterone-driven hypertension with FDA approval by ...

A novel treatment, an aldosterone synthase inhibitor, safely and consistently lowered blood pressure in individuals with ...

A Mexico City startup has achieved the Western Hemisphere's first SaMD regulatory approval for its proprietary AI-powered ...

Survey also found a shortage of 82.2% physicians and 83.2% surgeons at community health centre-level facilities, considered ...

Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...